Gynesonics

OverviewSuggest Edit

Gynesonics is a company that develops an ablation device for treating uterine fibroids. Its Sonata (Sonography-Guided Transcervical Fibroid Ablation) system is intended for the diagnostic intrauterine imaging and transcervical treatment of symptomatic uterine fibroids, including those associated with heavy menstrual bleeding.

TypePrivate
Founded2005
HQRedwood City, CA, US
Websitegynesonics.com

Latest Updates

Employees (est.) (Oct 2021)101(+3%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Gynesonics

Chris Owens

Chris Owens

President, CEO & Director
Jordan Bajor

Jordan Bajor

Chief Operating Officer
Susan Stimson

Susan Stimson

Director
Jiayu Chen

Jiayu Chen

Vice President, Engineering and Advanced Technologies
Taraneh G. Farazi

Taraneh G. Farazi

Senior Vice President, Global Clinical Strategy and Scientific Innovation
Diane King

Diane King

Vice President, Regulatory Affairs and Quality Assurance
Show more

Gynesonics Office Locations

Gynesonics has offices in Redwood City and Beuningen
Redwood City, CA, US (HQ)
600 Chesapeake Dr
Beuningen, NL
De Haaghe 2
Show all (2)

Gynesonics Financials and Metrics

Summary Metrics

Founding Date

2005

Gynesonics total Funding

$153.4 m

Gynesonics latest funding size

$75 m

Time since last funding

3 years ago

Gynesonics investors

Gynesonics's latest funding round in January 2019 was reported to be $75 m. In total, Gynesonics has raised $153.4 m
Show all financial metrics

Gynesonics Operating Metrics

Jul, 2020

Awards

3

Patents and Patent Applications

10

Trademarks (US)

3
Show all operating metrics

Gynesonics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

91/100

SecurityScorecard logo

Gynesonics Online and Social Media Presence

Embed Graph

Gynesonics Blogs

Gynesonics Announces First Office-Based Sonata Procedure in the State of Texas

Dr. John Thoppil, Current President of the Texas Association of Obstetricians and Gynecologists (TAOG), Performs Sonata Procedure in Austin Redwood City, CA, October 5, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine…

Gynesonics Names Robert Brown Chief Financial Officer

Redwood City, CA, September 29, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that Robert Brown has joined the company as Chief Financial Officer, starting immediately. Mr. Brown’s backgro…

Gynesonics Announces FDA Clearance of Next Generation Sonata System

The Only Transcervical, Incisionless System for Radiofrequency Ablation of Fibroids Provides New Benefits through Features Such as Increased Range of Ablation Sizes, a New User Interface, and Validation of Additional Low Temperature Hospital Reprocessing Systems Redwood City, CA, September 16, 2021 …

Gynesonics Announces Anthem, the Second Largest Healthcare Payer in the U.S., Issues Medical Necessity Coverage for the Treatment of Symptomatic Uterine Fibroids with the Sonata Procedure

 Anthem’s decision significantly increases nationwide access for Sonata Redwood City, CA, September 14, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced Anthem, Inc., the largest managed health car…

Gynesonics Announces Expert Group of European Gynecologic Surgeons Publishes Consensus on the Broad Use of the Sonata Technology in a New Treatment Strategy for Symptomatic Fibroids

The Combined Clinical Experience of Over 1000 Sonata Procedures, Across Three Countries, Drives New Recommendation for Sonata as a First Line Therapy for Fibroid Treatment Redwood City, CA, August 11, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive s…

Gynesonics Announces Positive Payer Coverage Issued by Blue Cross Blue Shield of Florida (Florida Blue) for the Sonata Treatment

 Florida Blue is the Largest Healthcare Payer in that State Redwood City, CA, June 11, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today Blue Cross Blue Shield of Florida (Florida Blue) has re…
Show more

Gynesonics Frequently Asked Questions

  • When was Gynesonics founded?

    Gynesonics was founded in 2005.

  • Who are Gynesonics key executives?

    Gynesonics's key executives are Chris Owens, Jordan Bajor and Susan Stimson.

  • How many employees does Gynesonics have?

    Gynesonics has 101 employees.

  • Who are Gynesonics competitors?

    Competitors of Gynesonics include Infogene, Layla Wellness and AblaCare.

  • Where is Gynesonics headquarters?

    Gynesonics headquarters is located at 600 Chesapeake Dr, Redwood City.

  • Where are Gynesonics offices?

    Gynesonics has offices in Redwood City and Beuningen.

  • How many offices does Gynesonics have?

    Gynesonics has 2 offices.